Lipoprotein (a) measurement: potential for personalized cardiovascular disease management in a patient with acute myocardial infarction
Arch Med Sci
.
2024 May 3;20(3):1043-1047.
doi: 10.5114/aoms/188252.
eCollection 2024.
Authors
Jakub Michal Zimodro
1
,
Aleksandra Gąsecka
1
,
Piotr Arski
1
,
Jonas Schwarz
2
,
Maciej Banach
3
,
Ioanna Gouni-Berthold
2
Affiliations
1
1 Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
2
Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Faculty of Medicine and University Hospital, Cologne, Germany.
3
Department of Preventive Cardiology and Lipidology, Medical University of Lodz, Lodz, Poland.
PMID:
39050163
PMCID:
PMC11264059
DOI:
10.5114/aoms/188252
No abstract available
Grants and funding
Funding
No external funding.